/PRNewswire/ LISCure Biosciences Inc., a clinical-stage biotech developing advanced microbiome technology with precision targets, announced a multi-year.
/PRNewswire/ LISCure Biosciences Inc., a leading biotech focused on microbial-based therapeutics, announced that it has executed a research collaboration.
LISCure Biosciences received clinical approval for two microbiome programs targeting autoimmune disease and NASH prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic - Press Release wiredprnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wiredprnews.com Daily Mail and Mail on Sunday newspapers.